Dissemination plans {31a}
cancer
CANCER
The results will be made available in peer-reviewed journals and presented at conferences. Both positive and negative results will be reported. In addition, a “corona-compliant” hybrid symposium will take place, at which the results of the study will be presented to experts and the general public and an exchange of information about the current possibilities and limitations of shared decision-making in the context of (lung) cancer therapy will be facilitated.